Adolescent exposure to toxic volatile organic chemicals from e-cigarettes

Pediatrics

Volumn 141, Issue 4, 2018, Pages

  Rubinstein, Mark L ^a   Delucchi, Kevin ^b,c   Benowitz, Neal L ^d   Ramo, Danielle E ^b,c  

^a Division Adolescent Medicine   (United States)

^b Department of Psychiatry ^*  (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Division of Clinical Pharmacology and Experimental Therapeutics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; ACROLEIN; ACRYLAMIDE; ACRYLONITRILE; BENZENE; CARCINOGEN; COTININE; CREATININE; CROTONALDEHYDE; ETHYLENE OXIDE; PROPYLENE OXIDE; VOLATILE ORGANIC COMPOUND; BIOLOGICAL MARKER;

ADOLESCENT; ARTICLE; CONTROLLED STUDY; ELECTRONIC CIGARETTE; FEMALE; HUMAN; MALE; METABOLITE; PRIORITY JOURNAL; SALIVA; URINARY EXCRETION; URINE LEVEL; ADOLESCENT BEHAVIOR; ADVERSE EVENT; DRUG EFFECT; LONGITUDINAL STUDY; METABOLISM; PHYSIOLOGY; PROCEDURES; TOBACCO; TOXICITY; URINE; VAPING;

ADOLESCENT; ADOLESCENT BEHAVIOR; BIOMARKERS; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; SALIVA; TOBACCO PRODUCTS; VAPING; VOLATILE ORGANIC COMPOUNDS;

EID: 85044723880     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2017-3557     Document Type: Article

References (37)

1. Grana RA, Ling PM. "Smoking revolution": A content analysis of electronic cigarette retail Websites. Am J Prev Med. 2014;46(4):395-403
2. Johnston LD, Miech RA, O'Malley PM, Bachman JG, Schulenberg JE. Use of alcohol, cigarettes, and number of illicit drugs declines among U.S. teens. 2014. Available at: Http://www.monitoringthefutu re.org/pressreleases/14cigpr. pdf. Accessed January 6, 2015
3. US Department of Health and Human Services. E-Cigarette Use Among Youth and Young Adults: A Report of the Surgeon General-Executive Summary. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2016
4. Kong G, Morean ME, Cavallo DA, Camenga DR, Krishnan-Sarin S. Reasons for electronic cigarette experimentation and discontinuation among adolescents and young adults. Nicotine Tob Res. 2015;17(7):847-854
5. Carroll Chapman SL, Wu LT. E-cigarette prevalence and correlates of use among adolescents versus adults: A review and comparison. J Psychiatr Res. 2014;54:43-54
6. Wills TA, Knight R, Williams RJ, Pagano I, Sargent JD. Risk factors for exclusive e-cigarette use and dual e-cigarette use and tobacco use in adolescents. Pediatrics. 2015;135(1). Available at: Www.pediatrics.org/cgi/content/full/135/1/e43
7. Grana R, Benowitz N, Glantz SA. E-cigarettes: A scientific review. Circulation. 2014;129(19):1972-1986
8. Laino T, Tuma C, Moor P, Martin E, Stolz S, Curioni A. Mechanisms of propylene glycol and triacetin pyrolysis. J Phys Chem A. 2012;116(18):4602-4609
9. Henderson TR, Clark CR, Marshall TC, Hanson RL, Hobbs CH. Heat degradation studies of solar heat transfer fluids. Sol Energy. 1981;27(2):121-128
10. Feng Z, Hu W, Hu Y, Tang MS. Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair. Proc Natl Acad Sci USA. 2006;103(42):15404-15409
11. Kosmider L, Sobczak A, Fik M, et al. Carbonyl compounds in electronic cigarette vapors: Effects of nicotine solvent and battery output voltage. Nicotine Tob Res. 2014;16(10):1319-1326
12. Jensen RP, Luo W, Pankow JF, Strongin RM, Peyton DH. Hidden formaldehyde in e-cigarette aerosols. N Engl J Med. 2015;372(4):392-394
13. Hecht SS, Carmella SG, Kotandeniya D, et al. Evaluation of toxicant and carcinogen metabolites in the urine of e-cigarette users versus cigarette smokers. Nicotine Tob Res. 2015;17(6):704-709
14. Pulvers K, Emami AS, Nollen NL, et al. Tobacco consumption and toxicant exposure of cigarette smokers using electronic cigarettes. Nicotine Tob Res. 2018;20(2):206-214
15. Wild CP, Kleinjans J. Children and increased susceptibility to environmental carcinogens: Evidence or empathy? Cancer Epidemiol Biomarkers Prev. 2003;12(12):1389-1394
16. Jacob P III, Yu L, Duan M, Ramos L, Yturralde O, Benowitz NL. Determination of the nicotine metabolites cotinine and trans-3?-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: Biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity. J Chromatogr B Analyt Technol Biomed Life Sci. 2011;879(3-4):267-276
17. Jacob P III, Wilson M, Benowitz NL. Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids. J Chromatogr A. 1981;222(1):61-70
18. Hecht SS, Stepanov I, Carmella SG. Exposure and metabolic activation biomarkers of carcinogenic tobaccospecific nitrosamines. Acc Chem Res. 2016;49(1):106-114
19. Goniewicz ML, Havel CM, Peng MW, et al. Elimination kinetics of the tobaccospecific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. Cancer Epidemiol Biomarkers Prev. 2009;18(12):3421-3425
20. Jacob P III, Havel C, Lee DH, Yu L, Eisner MD, Benowitz NL. Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometry. Anal Chem. 2008;80(21):8115-8121
21. Gregg EO, Minet E, McEwan M. Urinary biomarkers of smokers' exposure to tobacco smoke constituents in tobacco products assessment: A fit for purpose approach. Biomarkers. 2013;18(6):467-486
22. Benowitz NL, Nardone N, Jain S, et al. Comparison of urine 4-(methylnitrosamino)-1-(3)pyridyl-1-butanol and cotinine for assessment of active and passive smoke exposure in urban adolescents. Cancer Epidemiol Biomarkers Prev. 2017, In press.
23. Carmella SG, Chen M, Han S, et al. Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers. Chem Res Toxicol. 2009;22(4):734-741
24. Wei B, Alwis KU, Li Z, et al. Urinary concentrations of PAH and VOC metabolites in marijuana users. Environ Int. 2016;88:1-8
25. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23(2):133-139
26. St Helen G, Jacob P III, Peng M, Dempsey DA, Hammond SK, Benowitz NL. Intake of toxic and carcinogenic volatile organic compounds from secondhand smoke in motor vehicles. Cancer Epidemiol Biomarkers Prev. 2014;23(12):2774-2782
27. Jain RB. Distributions of selected urinary metabolites of volatile organic compounds by age, gender, race/ethnicity, and smoking status in a representative sample of U.S. adults. Environ Toxicol Pharmacol. 2015;40(2):471-479
28. Goniewicz ML, Gawron M, Smith DM, Peng M, Jacob P III, Benowitz NL. Exposure to nicotine and selected toxicants in cigarette smokers who switched to electronic cigarettes: A longitudinal within-subjects observational study. Nicotine Tob Res. 2017;19(2):160-167
29. Gorukanti A, Delucchi K, Ling P, Fisher-Travis R, Halpern-Felsher B. Adolescents' attitudes towards e-cigarette ingredients, safety, addictive properties, social norms, and regulation. Prev Med. 2017;94:65-71
30. Bekki K, Uchiyama S, Ohta K, Inaba Y, Nakagome H, Kunugita N. Carbonyl compounds generated from electronic cigarettes. Int J Environ Res Public Health. 2014;11(11):11192-11200
31. Uchiyama S, Ohta K, Inaba Y, Kunugita N. Determination of carbonyl compounds generated from the e-cigarette using coupled silica cartridges impregnated with hydroquinone and 2, 4-dinitrophenylhydrazine, followed by high-performance liquid chromatography. Anal Sci. 2013;29(12):1219-1222
32. Benowitz NL, Fraiman JB. Cardiovascular effects of electronic cigarettes. Nat Rev Cardiol. 2017;14(8):447-456
33. Romagna G, Allifranchini E, Bocchietto E, Todeschi S, Esposito M, Farsalinos KE. Cytotoxicity evaluation of electronic cigarette vapor extract on cultured mammalian fibroblasts (ClearStream-LIFE): Comparison with tobacco cigarette smoke extract. Inhal Toxicol. 2013;25(6):354-361
34. Farsalinos KE, Romagna G, Allifranchini E, et al. Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells. Int J Environ Res Public Health. 2013;10(10):5146-5162
35. Allen JG, Flanigan SS, LeBlanc M, et al. Flavoring chemicals in e-cigarettes: Diacetyl, 2, 3-pentanedione, and acetoin in a sample of 51 products, including fruit-, candy-, and cocktail-flavored e-cigarettes. Environ Health Perspect. 2016;124(6):733-739
36. Huestis MA. Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol. In: Pertwee RG, ed. Handbook of Experimental Pharmacology. Vol 168. New York, NY: Springer; 2005:657-690
37. Buchan BJ, L Dennis M, Tims FM, Diamond GS. Cannabis use: Consistency and validity of self-report, on-site urine testing and laboratory testing. Addiction. 2002;97(suppl 1):98-108